Cornejo, Rubelio

Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial

Kremsner, P. G., Ahuad Guerrero, R. A., Arana-Arri, E., Aroca Martinez, G. J., Bonten, M., Chandler, R., Corral, G., De Block, E. J. L., Ecker, L., Gabor, J. J., et al. (2022) · The Lancet Infectious Diseases

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies

Cited by 172

Systems Biology-Based Assessment of Immune Responses to Whole Cell and Acellular Pertussis Vaccines: Rationale, Methodology and Enrollment Procedures for Omics Workflows

Leguia, M., Vila-Sanjurjo, A., Juarez, D., Garcia-Glaessner, A., Gil, A. I., Alvarez, M., Cornejo, R., Cherikh, S., Gelber, C. E., Goll, J. B., et al. (2024) · npj Vaccines

Bacterial Infections and VaccinesDiphtheria, Corynebacterium, and Tetanus

Cited by 1

Systems biology-based assessment of immune responses to whole cell and acellular pertussis vaccines

Leguia, M., Vila-Sanjurjo, A., Juarez, D., Garcia-Glaessner, A., Gil, A. I., Alvarez, M., Cornejo, R., Cherikh, S., Gelber, C. E., Goll, J. B., et al. (2025) · npj Vaccines

Bacterial Infections and VaccinesDiphtheria, Corynebacterium, and Tetanus

Cited by 1